Indexed logomarkindexed.vc
I

Innovalve

Acquired

Israel · $17.7M raised

Biotech
Healthcare
Business Model
B2B
Total Funding
$17.7M
Last Round
$7.2M Series BJun 2022
Rounds
2

About

Revolutionizing mitral heart valve replacement therapy

Summary

Innovalve is a Biotech company based in Israel. It has raised $17.7M in total across 2 rounds, most recently a $7.2M Series B round in Jun 2022. Investors include ALIVE Israel HealthTech Fund, Edwards Lifesciences and OurCrowd.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

AcquisitionJul 2024
$300.0M

Sign up to see all 3 rounds

Full funding history, per-round amounts, and investor participation.

Investors

ALIVE Israel HealthTech Fund

Lead

2 rounds

Edwards Lifesciences

Lead

1 round

OurCrowd

1 round

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private Equity·$3.9B·Jan 2019
IVI-RMA

Global fertility clinics platform

Valencia, Spain5001–10000Biotech, Healthcare
Private Equity·$3.3B·Apr 2022
Altos Labs

Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

San Francisco, United States501–1000Life Sciences, Biotech
Series A·$3.0B·Jan 2022
Warner ChilcottClosed

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private Equity·$3.0B·Jan 2004
inVentiv HealthAcquired

Biopharmaceutical services company

Burlington, United States5001–10000Biotech, Healthcare
Private Equity·$3.0B·May 2017
BeiGeneIPO

Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...

Cambridge, United States10001+Biotech, Oncology
Corporate Round·$2.8B·Jan 2020